Konkuk University Hospital
17
3
3
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
29%
5 trials in Phase 3/4
18%
2 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Exploratory Evaluation of the Digital Therapeutic Device Zenicom for Subacute Stroke Aphasia
Role: collaborator
Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)
Role: collaborator
The Nationwide Real-world Status of Oral Corticosteroid Use in Patients With Asthma
Role: collaborator
Exacerbations and Their Outcomes International (EXACOS International)
Role: collaborator
Addressing the Risks of Long-Term Opioid Therapy in Chronic Noncancer Pain
Role: collaborator
Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
Role: collaborator
Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma
Role: collaborator
The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure
Role: collaborator
A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg
Role: collaborator
To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma
Role: collaborator
Changing in Skin Physiology After Microdroplet Placement of Stabilized Hyaluronic Acid in Aging Faces
Role: lead
Efficacy Study of Pneumococcal Vaccination in Crohn's Disease
Role: collaborator
The Usefulness of I-scan in Screening Colonoscopy
Role: lead
The Efficacy of i-Scan for Detecting Reflux Esophagitis
Role: lead
Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients
Role: collaborator
The Effect of Bowel Preparation Status on the Polyp Missing Rate
Role: lead
A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer
Role: collaborator
All 17 trials loaded